Expression of apoptosis proteins in chronic myelogenous leukemia
Open Access
- 31 May 2001
- Vol. 91 (11) , 1964-1972
- https://doi.org/10.1002/1097-0142(20010601)91:11<1964::aid-cncr1221>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A Matter of Life and Cell DeathScience, 1998
- To Die or Not to DieJAMA, 1998
- Downregulation of Bcr-Abl in K562 cells restores susceptibility to apoptosis: Characterization of the apoptotic deathCell Death & Differentiation, 1997
- Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]Blood, 1996
- BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agentsBlood, 1995
- Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.Proceedings of the National Academy of Sciences, 1995
- BCR-ABL: An Anti-Apoptosis Gene in Chronic Myelogenous LeukemiaLeukemia & Lymphoma, 1995
- Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemiaBlood, 1994
- BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death [published erratum appears in Blood 1994 Jun 15;83(12):3835]Blood, 1994
- Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemiaThe American Journal of Medicine, 1990